A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

被引：0
|
作者：
Michael Willis
Knut Ödegaard
Ulf Persson
Johan Hedbrant
Dan Mellström
Mats Hammar
机构：
[1] IHE,The Swedish Institute for Health Economics
[2] University of Linköping,Systems Analysis Group
[3] Sahlgrenska University Hospital,Geriatric Clinic
[4] University Hospital,Obstetrics and Gynecology, Faculty of Health Sciences
来源：
Clinical Drug Investigation | 2001年 / 21卷
关键词：
Bone Mineral Density; Incremental Cost; Forearm Fracture; Osteoporotic Woman; Tibolone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 127
页数：12
相关论文
共 50 条
  • [1] A cost-effectiveness model of tibolone as treatment for the prevention of osteoporotic fractures in postmenopausal women in Sweden
    Willis, M
    Ödegaard, K
    Persson, U
    Hedbrant, J
    Mellström, D
    Hammar, M
    [J]. CLINICAL DRUG INVESTIGATION, 2001, 21 (02) : 115 - 127
  • [2] The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
    Stevenson, M.
    Davis, S.
    Lloyd-Jones, M.
    Beverley, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (04) : 1 - +
  • [3] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [4] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    [J]. Osteoporosis International, 2004, 15 : 862 - 871
  • [5] Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Boonen, Annelies
    Dirksen, Carmen D.
    Ben Sedrine, Wafa
    Reginster, Jean-Yves
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 19 - 28
  • [6] Cost-effectiveness of teriparatide (Forteo) in the prevention of osteoporotic fractures among men and postmenopausal women in Australia
    Graham-Clarke, PL
    Lees, M
    Wolthers, T
    Thiebaud, D
    Price, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 297 - 297
  • [7] Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Christensen, PM
    Brixen, K
    Gyrd-Hansen, D
    Kristiansen, IS
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (05) : 387 - 396
  • [8] Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Reginster, Jean-Yves
    [J]. BONE, 2010, 47 (01) : 34 - 40
  • [9] COST-EFFECTIVENESS OF PRIMARY PREVENTION FOR OSTEOPOROTIC HIP FRACTURES IN ELDERLY WOMEN
    Comas, M.
    Posso, M.
    Louro, J.
    Espallargues, M.
    Tebe, C.
    Domingo, L.
    Castells, X.
    [J]. VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [10] Cost-effectiveness of teriparatide in the prevention of osteoporotic fractures in Australian men and women
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Price, N
    Grainger, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S12 - S13
12345